Skip to main content
Clinical Trials/IRCT20230822059222N2
IRCT20230822059222N2
Completed
Phase 2

A Randomized Clinical Trial to Evaluate the Efficacy of Systemic Treatment in Combination with Topical Tacrolimus versus Systemic Treatment Alone in Managing Skin Involvement of Patients with Idiopathic Granulomatous Mastitis

Shiraz University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Idiopathic Granulomatous Mastitis.
Sponsor
Shiraz University of Medical Sciences
Enrollment
36
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • A confirmed diagnosis of idiopathic granulomatous mastitis (IGM) based on histopathological examination
  • The severity of involvement should be grade II, III, or IV according to the modified classification of Yuan et al
  • consent to participate in the study

Exclusion Criteria

  • breast carcinoma or other malignancies
  • require surgical treatment
  • systemic diseases such as vasculitis, collagen vascular disease, or sarcoidosis
  • a risk factor for steroid therapy, such as hypertension or diabetes mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials